Carbohydrate Tumor Marker: Basis for a Simple Test for Colorectal Cancer

  • Abulkalam M. Shamsuddin
  • Kosaku Sakamoto
Part of the Advances in Experimental Medicine and Biology book series (AEMB, volume 375)

Abstract

Large intestinal cancer (LIC) is one of the commonest cancers in the industrialized world. It is ranked among the major causes of cancer death in the United States and other Western countries.1 Because of the magnitude of the health problem and associated cost in life and materials, control of this cancer is vital. Prevention is one of the methods of cancer control, and detection of the cancer at the very early stage of the disease is fundamental to prevention. Early detection in its turn is dependent on screening the population (or those at risk) for the disease. Without screening, a 50-year-old person at average risk has approximately a 530 in 10,000 chance of developing invasive colorectal cancer during the rest of her/his life.2 A host of currently available diagnostic assays have been recommended and are in use for LIC screening.3 The common ones are the fecal occult blood tests (FOBT), barium enema X-rays, and endoscopic visualization.3 The cost-effectiveness of these vary tremendously; their use as screening assays is therefore seriously in question.2–7 On one hand, FOBTs are relatively inexpensive2,3 (approximately $10) but are not cost-effective due to their inaccuracies. While the cost of barium enemas and colonoscopies can range from $250–800, they are highly accurate, although marred by the discomfort they cause.

Keywords

Sialic Acid Fecal Occult Blood Test Precancerous Lesion Alcian Blue Basic Fuchsin 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    C.C. Boring, T.S. Squires, and T. Tong, Cancer statistics, 1993, CA 43:7 (1993).PubMedGoogle Scholar
  2. 2.
    D.M. Eddy, Screening for colorectal cancer, Ann Intern Med 113:373 (1990).PubMedCrossRefGoogle Scholar
  3. 3.
    A.M. Shamsuddin, “Diagnostic Assays for Colon Cancer” CRC Press, Boca Raton, FL (1991).Google Scholar
  4. 4.
    J.L. Wagner, B. Duffy, S. Wadhwa, and L. Jakubowski, Costs and effectiveness of colorectal cancer screening in the elderly, Background paper 5, Office of Technology Assessment, U.S. Congress, Washington, D.C. (1990).Google Scholar
  5. 5.
    J.E. Allison and F. Feldman, Cost benefits of Hemoccult screening for colorectal carcinoma, Dig Dis Sci 30:860 (1985).PubMedCrossRefGoogle Scholar
  6. 6.
    MJ. Barry, A.G. Mulley, and J.M. Richter, The effect of workup strategy on the cost-effectiveness of fecal occult blood screening for colorectal cancer, Gastroenterology 93:301 (1987).PubMedGoogle Scholar
  7. 7.
    W.L. England, JJ. Halls, and V.B. Hunt, Strategies for screening colorectal carcinoma, Med Decis Making 9:3 (1989).PubMedCrossRefGoogle Scholar
  8. 8.
    D.A. Ahlquist, Occult blood screening: Obstacle to effectiveness, Cancer 70:1259 (1992).PubMedCrossRefGoogle Scholar
  9. 9.
    E.J. Stanbridge, Identifying tumor suppressor genes in human colorectal cancer, Science 247:12 (1990).PubMedCrossRefGoogle Scholar
  10. 10.
    D. Sidransky, T. Tokino, S.R. Hamilton, K.W. Kinzler, B. Levine, P. Frost, and B. Vogelstein, Identification of ras oncogene mutations in the stool of patients with curable colorectal tumors, Science 256:102 (1992).PubMedCrossRefGoogle Scholar
  11. 11.
    M.I. Filipe and A.C. Branfoot, Abnormal patterns of mucus secretion in apparently normal mucosa of large intestine with carcinoma, Cancer 34:282 (1974).PubMedCrossRefGoogle Scholar
  12. 12.
    A.K.M. Shamsuddin and B.F. Trump, Colonie epithelium. II. In vivo studies of colon carcinogenesis. Light microscopic, histochemical, and ultrastructural studies of histogenesis of azoxymethane-induced colon carcinomas in Fischer 344 rats, JNCI 66:389 (1981).PubMedGoogle Scholar
  13. 13.
    A.K.M. Shamsuddin and B.F. Trump, Colon epithelium. III. In vitro studies of colon carcinogenesis in Fischer 344 rats: N methyl-N′-nitro-N-nitrosoguanidine-induced changes in colon epithelium in expiant culture, JNCI 66:403 (1981).PubMedGoogle Scholar
  14. 14.
    A.K.M. Shamsuddin, L. Weiss, P.C. Phelps, and B.F. Trump, Colon epithelium. IV. Changes in human colon mucosa adjacent to and remote from carcinomas of the colon, JNCI 66:413 (1981).PubMedGoogle Scholar
  15. 15.
    EJ. Bloom, S.H. Itzkowitz, and Y.S. Kim, Carbohydrate tumor markers in colon cancer and polyps, in: Colon Cancer Cells, M.P. Moyer and G.H. Poste, eds., Academic Press, New York (1990).Google Scholar
  16. 16.
    A.K.M. Shamsuddin, P.C. Phelps, and B.F. Trump, Human large intestinal epithelium: Light microscopy, histochemistry and ultrastructure, Hum Pathol 13:790 (1982).PubMedCrossRefGoogle Scholar
  17. 17.
    A.P. Corfield, J.B. Rainey, J.R. Clamp, and S.A Wagner, Rat colonic mucosal cell sialic acid metabolism in azoxymethane induced tumors, Biochem Biophys Acta 840:264 (1985).PubMedCrossRefGoogle Scholar
  18. 18.
    P.E. Reid, C.F.A. Culling, W.L. Dunn, and M.G. Clay, Chemical and histochemical studies of normal and diseased human gastrointestinal tract. I. A comparison between histologically normal colon, colonic tumours, ulcerative colitis and diverticular disease of the colon, Histochem J 16:235 (1984).PubMedCrossRefGoogle Scholar
  19. 19.
    C.F.A. Culling, P.E. Reid, and W.L. Dunn, A histochemical comparison of the O-acylated sialic acids of the epithelial mucins in ulcerative colitis, Crohn’s disease and normal controls, J Clin Pathol 32:1272 (1979).PubMedCrossRefGoogle Scholar
  20. 20.
    J.T. James, A.M. Shamsuddin, and B.F. Trump, A comparative study of the morphological and histochemical changes induced in the large intestine of ICR/Ha and C57B1/Ha mice by 1,2-dimemylhydrazine, JVCI 71:955 (1983).Google Scholar
  21. 21.
    P.A. Dawson and M.I. Filipe, An ultrastructural and histochemical study of the mucous membrane adjacent to and remote from carcinoma of the colon, Cancer 37:2388 (1976).PubMedCrossRefGoogle Scholar
  22. 22.
    D.M. Marcus, The ABO and Lewis blood group system, N Engl J Med 280:994 (1969).PubMedCrossRefGoogle Scholar
  23. 23.
    B.F. Atkinson, C.S. Ernst, M. Herlyn, Z. Steplewski, H.F. Sears, and H. Koprowski, Gastrointestinal cancer-associated antigen in immunoperoxidase assay, Cancer Res 42:4820 (1982).PubMedGoogle Scholar
  24. 24.
    J.W. Arends, C. Verstynen, F.T. Bosman, J. Hilgers, and Z. Steplewski, Distribution of monoclonal antibody-defined monosialoganglioside in normal and cancerous human tissues: An immunoperoxidase study, Hybridoma 2:219 (1983).PubMedCrossRefGoogle Scholar
  25. 25.
    E. Gong, S. Hirohashi, Y. Shimosato, M. Watanabe, Y. Ito, S. Teshima, and S. Kodaira, Expression of carbohydrate antigen 19-9 and stage specific embryonic antigen 1 in nontumorous and tumorous epithelia of the human colon and rectum, JNCI 75:447 (1985).PubMedGoogle Scholar
  26. 26.
    S.H. Itzkowitz, M. Yuan, Y. Fukushi, A. Palekar, P.C. Phelps, A.M. Shamsuddin, B.F. Trump, S. Hakomori, and Y.S. Kim, Lewisx — and sialylated Lewisx-related antigen expression in human malignant and nonmalignant colonie tissues, Cancer Res 46:2627 (1986).PubMedGoogle Scholar
  27. 27.
    H.F. van den Ingh, D.J. Ruiter, J. Griffioen, G.N.P. van Muijen, and S. Ferrone, HLA antigens in colorectal tumors — low expression of HLA class I antigens in mucinous colorectal carcinomas, Br J Cancer 55:125 (1987).PubMedCrossRefGoogle Scholar
  28. 28.
    M.E.F. Smith, S.G.E. Marsh, J.G. Bodmer, K. Gelsthorpe, and W.F. Bodmer, Loss of HLA-A,B,C allele products and lymphocyte function-associated antigen 3 in colorectal neoplasia, Proc Natl Acad Sci (USA) 86:5557 (1989).CrossRefGoogle Scholar
  29. 29.
    G. Tsioulias, T.A. Godwin, M.F. Goldstein, CJ. McDougall, S.S. Ngoi, J.J. DeCosse, and B. Rigas, Loss of colonie HLA antigens in familial adenomatous polyposis, Cancer Res 52:3449 (1992).PubMedGoogle Scholar
  30. 30.
    CJ. McDougall, S.S. Ngoi, I.S. Goldman, T. Godwin, J. Felix, J J. DeCosse, and B. Rigas, Reduced expression of HLA Class I and II antigens in colon cancer, Cancer Res 50:8023 (1990).PubMedGoogle Scholar
  31. 31.
    P. Demant, Histocompatibility and the genetics of tumour resistance, J Immunogenet 13:61 (1986).PubMedCrossRefGoogle Scholar
  32. 32.
    WJ. Bateman, R. Fiera, N. Matthews, and A.G. Morris, Inducibility of class II major histocompatibility complex antigens by interferon y is associated with reduced tumorigenicity in C3H mouse fibroblasts transformed by v-Ki-ras, J Exp Med 173:193 (1991).PubMedCrossRefGoogle Scholar
  33. 33.
    R. Lotan, E. Skutelsky, D. Danon, and N. Sharon, The purification, composition and specificity of anti-T lectin from peanut (Arachis hypogaea), J Biol Chem 250:8518 (1975).PubMedGoogle Scholar
  34. 34.
    C.R. Boland, C.K. Montgomery, and Y.S. Kim, Alterations in human colonie mucin occurring with cellular differentiation and malignant transformation, Proc Natl Acad Sci USA 79:2051 (1982).PubMedCrossRefGoogle Scholar
  35. 35.
    H.S. Cooper, Peanut lectin-binding sites in large bowel carcinoma, Lab Invest 47:383 (1982).PubMedGoogle Scholar
  36. 36.
    T.F. Orntoft, N.R Ole Mors, G. Eriksen, N.O. Jacobsen, and H.S. Poulsen, Comparative immunoperoxidase demonstration of T-antigens in human colorectal carcinomas and morphologically abnormal mucosa, Cancer Res 45:447 (1985).PubMedGoogle Scholar
  37. 37.
    K.L. McKenzie, D.M. Purnell, and A.M. Shamsuddin, Expression of carcinoembryonic antigen, T-antigen and oncogene products as markers of neoplastic and preneoplastic colonic mucosa, Human Pathol 18:1282 (1987).CrossRefGoogle Scholar
  38. 38.
    B.A. Schulte and S.S. Spicer, Light microscopic histochemical detection of sugar residues in secretory glycoproteins of rodent and human tracheal glands with lectin-horseradish peroxidase conjugates and the galactose oxidase-Schiff sequence, J Histochem Cytochem 31:391 (1983).PubMedCrossRefGoogle Scholar
  39. 39.
    A.M. Elsayed and A.M. Shamsuddin, Detection of altered glycoconjugate in preneoplastic and neoplastic human large intestinal epithelium by galactose oxidase-Schiff sequence, Lab Invest 56:22A (1987).Google Scholar
  40. 40.
    A.M. Shamsuddin and A.M. Elsayed, A test for detection of colorectal cancer, Hum Pathol 19:7 (1988).PubMedCrossRefGoogle Scholar
  41. 41.
    A.M. Shamsuddin, A.M. Elsayed, and G.A. Jockle, Screening test for large intestinal cancer, U.S. Patent No. 4,857,457. (1989).Google Scholar
  42. 42.
    H.M. Xu, K. Sakamoto, and A.M. Shamsuddin, Detection of the tumor marker D-galactose-β[1→3]N-acetyl-D-galactosamine in colonic cancer and precancer, Arch Pathol Lab Med 116:1234 (1993).Google Scholar
  43. 43.
    J.B. Schreiber, R.G. Knodell, and A.K.M. Shamsuddin, Utilization of alterations in colonie mucus as a screening test for detecting colonie neoplasia, Am J Gastroenterol 83:1058(abs) (1988).Google Scholar
  44. 44.
    R.G. Knodell, E. Hale, M. Antos, H. Matossian, and A.K.M. Shamsuddin, A new screening test for detection of colon cancer utilizing neoplasia associated alterations in rectal mucus, Gastroenterology 94:A230(abs) (1988).Google Scholar
  45. 45.
    C.W. Mackett, III C. Wilson, T. Brna, and R.D. Kirkham, Comparison of a galactose oxidase test to Hemoccult in colorectal cancer screening, Am J Gastroenterol 84:1190(abs) (1989).Google Scholar
  46. 46.
    K. Sakamoto, G. Nakano, and Y. Nagamachi, A pilot study on the usefulness of a new test for mass screening of colorectal cancer in Japan, Gastroenterol Jpn 25:432 (1990).PubMedGoogle Scholar
  47. 47.
    M. Tada, H. Ohtsuka, A. Iso, S. Shimizu, M. Okamura, K. Aoki, and K. Kawai, Screening of colorectal cancer by testing rectal mucus for β-d-Gal[1→3]-d-GalNAc (T-antigen), J Kyoto Pref Univ Med 99:681 (1990).Google Scholar
  48. 48.
    K. Sakamoto, M. Muratani, T. Ogawa, and Y. Nagamachi, Colon cancer screening by a new test: A prospective study of asymptomatic population, Proc Am Assoc Cancer Res 32:168(abs) (1991).Google Scholar
  49. 49.
    A. Vcev, B. Pospihalj, D. Bozic, I. Candrlic, A. Vegar, L. Pinotic, and Z. Krucaj, The galactose oxidase test for detection of colorectal cancer, Exp Clin Gastroenterol 1:217 (1991).Google Scholar
  50. 50.
    D.-Y. Zhou, Y. Zhang, Z. Nai, L. Pam, B. Zhang, and W. Zhang, Screening of colorectal cancer by testing rectal mucus for T-antigen, Chinese J Digestion 11:261 (1991).Google Scholar
  51. 51.
    C. Sano, R. Kamishiro, H. Uogaeshi, S. Yamazaki, K. Tanaka, S. Mandokoro, R. Beppu, H. Yoshitake, T. Hideshima, T. Maekawa, and S. Inuzuka, A new screening test for colorectal cancer detection by T antigen, Jpn J Gastroenterol Surg 25:1568 (1992).CrossRefGoogle Scholar
  52. 52.
    A.R. Kristal, M.S. Baker, A.D. Feld, J.T. Ylvisaker, and K.A. Morse, Evaluation of a test for abnormal rectal mucus for early detection of colon cancer, Cancer Epidemiol Biomarkers Prev 1:303 (1992).PubMedGoogle Scholar
  53. 53.
    C. Mu, S. Li, B. Liu, and Z. Tian, The screening of colorectal cancer by enzymatic detection of β-d-Gal[1→3]-d-GalNAc in colorectal mucus, Proc of Chinese Acad Medical Sciences (1993) in press.Google Scholar
  54. 54.
    D.-Y. Zhou, F. Feng, Y. Zhang, Z. Lai, W. Zhang, L. Li, G. Xu T. Wan, D. Pan, D. Zhou, Y. Zhang, and S. Li, Comparison of Shams’ test for rectal mucus to an immunological test for fecal occult blood in large intestinal cancer screening: Analysis of 6480 asymptomatic subjects, submitted for publication (1992).Google Scholar
  55. 55.
    A.M. Shamsuddin and A. Ullah, Inositol hexaphosphate inhibits large intestinal cancer in F344 rats 5 months following induction by azoxymethane, Carcinogenesis 10:625 (1989).PubMedCrossRefGoogle Scholar
  56. 56.
    K. Sakamoto, G. Venkatraman, and A.M. Shamsuddin, Growth inhibition and differentiation of HT-29 cells by inositol hexaphosphate (InsP6), Proc Am Assoc Cancer Res 33:42(abs) (1992).Google Scholar

Copyright information

© Springer Science+Business Media New York 1994

Authors and Affiliations

  • Abulkalam M. Shamsuddin
    • 1
  • Kosaku Sakamoto
    • 2
  1. 1.Department of PathologyUniversity of Maryland School of MedicineBaltimoreUSA
  2. 2.First Department of SurgeryGunma University School of MedicineMaebashi, Gunma 371Japan

Personalised recommendations